Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole

International Ophthalmology

Volumn 27, Issue 6, 2007, Pages 391-394

  Zarkovic, Andrea ^a,b   Guest, Stephen ^a  

^a WAIKATO HOSPITAL   (New Zealand)

^b Greenlane Clinical Center   (New Zealand)

Author keywords

Endophthalmitis; Penetrating eye injury; Scedosporium apiospermum

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFTAZIDIME; LIVER ENZYME; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; VANCOMYCIN; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; CATARACT; CLINICAL FEATURE; CRYOTHERAPY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG WITHDRAWAL; ENDOPHTHALMITIS; FEMALE; HUMAN; IRIDECTOMY; IRIS DISEASE; LENSECTOMY; RASH; RETINA MACULA CYSTOID EDEMA; SCEDOSPORIUM APIOSPERMUM; SCHOOL CHILD; SIDE EFFECT; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

ANTIFUNGAL AGENTS; CHILD; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; EYE INJURIES, PENETRATING; FEMALE; HUMANS; INJECTIONS; MADUROMYCOSIS; PYRIMIDINES; SCEDOSPORIUM; TRIAZOLES; VITREOUS BODY;

EID: 36049007444     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-007-9095-0     Document Type: Article

References (21)

1. Sabo JA, Abdel-Rahman SM (2000) Voriconazole: A new triazole antifungal. Ann Pharmacother 34:1032-1043
2. Muijsers RBR, Goa KL, Scott LJ (2002) Voriconazole in the treatment of invasive Aspergillosis. Drugs 62:2655-2664
3. Gao H, Pennesi ME, Shah K et al (2004) Intravitreal voriconazole. An electrographic and histopathologic study. Arch Ophthalmol 122:1687-1692
4. Marco F, Pfaller MA, Messar SA, Jones RN (1998) Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. Med Mycol 36:433-436
5. Ghannoum MA, Kuhn DM (2002) Vorcionazole: Better chances for patients with invasive mycoses. Eur J Med Res 7:242-256
6. Espinel-Ingroff A, Boyle K, Sheehan DJ (2001) In vitro antifungal activities of voriconazole and reference against as determined by NCCLS methods: Review of the literature. Mycopathologia 150:101-115
7. Hariprasad SM, Mieler WF, Holz ER et al (2004) Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol 122:42-47
8. Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli W (2007) Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 51:239-244
9. Axelrod AJ, Peyman GA, Apple DJ (1973) Toxicity of intravitreal injection of amphotericin B. Am J Ophthalmol 76:578-583
10. Pfaller MA, Messar SA, Hollis RJ et al (2002) In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob Agents Chemother 46:1723-1727
11. Reis A, Sundmacher R, Tintelnot K et al (2000) Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole. Br J Ophthalmol 84:932-933
12. Garbino J, Ondrusova A, Baligvo E, Lew D, Bouchuiguir-Wafa K, Rohner P (2002) Successful treatment of Paecilomyces Iliacinus endophthalmitis with voriconazole. Scand J Infect Dis 24:701-703
13. Abraham OT, Manavathu EK, Cuthright JL et al (1999) In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole and amphotericin B. Diagn Microbiol Infect Dis 33:7-11
14. Rubin ZA, Somani J (2004) New options for the treatment of invasive fungal infections. Semin Oncol 31(2):91-99
15. Kim JE, Perkins SL, Harris GJ, Milwaukee W (2003) Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection. Arch Ophthalmol 121:735-737
16. Scott IU, Cruz-Villegas V, Flynn HW, Miller D (2004) Delayed onset bleb-associated endophthalmitis caused by Lecythophoria mutabilis. Am J Ophthalmol 137:583-585
17. Nulens E, Eggink C, Rijs AJMM, Wesseling P, Verweij PE (2003) Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. J Clin Microbiol 41(5):2261-2264
18. Nehemy MB, Vasconcelos-Santos DV, Torqueti-Costa L, Magalhaes E (2006) Chronic endophthalmitis due to Verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole. Retina 26:225-227
19. Figueroa M, Fortun J, Clement A, Fernandez de Arevalo B (2004) Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole. Retina 24:319-320
20. Kramer M, Kramer M, Blau H et al (2006) Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis. Ophthalmology 113:1184-1186
21. Sen P, Gopal L, Sen PR (2006) Intravitreal voriconazole for drug resistant fungal endophthalmitis. Case Ser Retina 26:935-939